Compounds > 4-methoxyamphetamine
Page last updated: 2024-08-23

4-methoxyamphetamine and Acute Hepatic Failure

4-methoxyamphetamine has been researched along with Acute Hepatic Failure in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Kumar, S; Lin, S; Schold, JD1
Bennett, J; Gozzini, S; Mayer, D; Mirza, DF; Muiesan, P; Perera, MT; Sharif, K1
Bowen, C; Gelas, T; Hartley, J; Mirza, DF; Muiesan, P; Sharif, K1

Other Studies

3 other study(ies) available for 4-methoxyamphetamine and Acute Hepatic Failure

ArticleYear
Impact of donation after circulatory death donor allografts on outcomes following liver transplantation for fulminant hepatic failure in the United States.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021, Volume: 21, Issue:1

    Topics: Allografts; Brain Death; Death; Graft Survival; Humans; Liver Failure, Acute; Liver Transplantation; Male; Retrospective Studies; Tissue and Organ Procurement; Tissue Donors; United States

2021
Safe use of segmental liver grafts from donors after cardiac death (DCD) in children with acute liver failure.
    Transplant international : official journal of the European Society for Organ Transplantation, 2009, Volume: 22, Issue:7

    Topics: Acute Disease; Child; Death; Female; Hepatectomy; Humans; Infant; Liver Failure, Acute; Liver Transplantation; Tissue Donors; Treatment Outcome

2009
Segmental ABO-incompatible liver graft from a donor after cardiac death in neonatal acute liver failure.
    Pediatric transplantation, 2012, Volume: 16, Issue:2

    Topics: ABO Blood-Group System; Death; Graft Rejection; Hemochromatosis; Humans; Immunosuppressive Agents; Infant, Newborn; Liver Failure, Acute; Liver Transplantation; Male; Tissue Donors

2012